ABSTRACT
Numerous studies have shown that treatment with pharmaceuticals within a continuum of care is highly cost-effective. Yet little is known about how the advent of managed care has affected the development and marketing of pharmaceutical products and consumers' access to pharmaceutical therapies and related services.
